PETALING JAYA: A clinical study conducted locally concluded that the anti-viral drug Ivermectin cannot be used in current Covid-19 treatment as it does not prevent severe cases of Covid-19, says the Health Ministry.
The I-Tech study by the Institute of Clinical Research (ICR) revealed that those who had Ivermectin, experienced three times more adverse events with the most common adverse effect being diarrhoea, said Health director-general Tan Sri Dr Noor Hisham Abdullah.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!